{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 6, "transaction_limit": 160, "filters": {"q": "", "ticker": "ARDX", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 6, "acquisition_count": 2, "disposal_count": 4, "acquisition_value": 51315.66, "acquisition_value_label": "$51.3K", "disposal_value": 701410.538, "disposal_value_label": "$701.4K", "net_value": -650094.878, "net_value_label": "$-650.1K", "flow_tone": "negative", "largest_value_label": "$490.5K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 6, "value": "752726.1980", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$752.7K"}], "days": [{"transaction_date": "2026-06-18", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 100.0}, {"transaction_date": "2026-07-15", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 100.0}], "side_mix": {"acquisitions": 2, "disposals": 4, "acquisition_share": 33.3, "disposal_share": 66.7}}, "company_flows": [{"symbol": "ARDX", "name": "Ardelyx Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "acquisitions": 2, "disposals": 4, "acquired_value": 51315.66, "acquired_value_label": "$51.3K", "disposed_value": 701410.538, "disposed_value_label": "$701.4K", "net_value": -650094.878, "net_value_label": "$-650.1K", "acquisition_share": 33.3, "disposal_share": 66.7, "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}], "company_overview": [{"symbol": "ARDX", "name": "Ardelyx Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "filings": 6, "acquisitions": 2, "disposals": 4, "acquired_value": 51315.66, "acquired_value_label": "$51.3K", "disposed_value": 701410.538, "disposed_value_label": "$701.4K", "net_value": -650094.878, "net_value_label": "$-650.1K", "acquisition_share": 33.3, "disposal_share": 66.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}], "transactions": [{"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "RAAB, MICHAEL", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 41668.0, "share_price": 5.062, "transaction_value": 210923.416, "fetched_at": "2026-07-31T10:53:34.415935+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}, {"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "RAAB, MICHAEL", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 20834.0, "share_price": 0.99, "transaction_value": 20625.66, "fetched_at": "2026-07-31T10:53:34.423129+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}, {"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "RAAB, MICHAEL", "executive_title": "Director, President & CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 20834.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:53:34.424733+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}, {"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "WILLIAMS, LAURA A", "executive_title": "Chief Patient Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 81898.0, "share_price": 5.989, "transaction_value": 490487.122, "fetched_at": "2026-07-13T21:48:52.873631+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}, {"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "WILLIAMS, LAURA A", "executive_title": "Chief Patient Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 31000.0, "share_price": 0.99, "transaction_value": 30690.0, "fetched_at": "2026-07-13T21:48:52.882263+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}, {"symbol": "ARDX", "name": "Ardelyx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-18", "executive": "WILLIAMS, LAURA A", "executive_title": "Chief Patient Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 31000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:48:52.885219+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ardx/", "research_links": {"chart": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/", "report": "/terminal/c293609b-7203-452c-9f0a-7f8bc7bfa84d/report/", "factor": "/factors/ticker/c293609b-7203-452c-9f0a-7f8bc7bfa84d/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}